2025 Utah Code
Title 58 - Occupations and Professions
Chapter 37 - Utah Controlled Substances Act
Section 3.5 - Drugs for behavioral health treatment.

Affected by 63I-1-258 on 7/1/2027

• (1)As used in this section:
  • (a)"Drug" means any form of psilocybin or methylenedioxymethamphetamine that is in federal Food and Drug Administration Phase 3 testing for an investigational drug described in 21 C.F.R. Part 312.
  • (b)"Healthcare system" means:
    • (i)a privately-owned, non-profit, vertically-integrated healthcare system that operates at least 15 licensed hospitals in the state; or
    • (ii)a health care system closely affiliated with an institution of higher education listed in Section 53H-1-102.

• (2)A healthcare system may develop a behavioral health treatment program that includes a treatment based on a drug that the healthcare system determines is supported by a broad collection of scientific and medical research.

• (3)A healthcare system described in Subsection (2):
  • (a)shall ensure that a drug used under the exclusive authority of this section is used by a patient only under the direct supervision and control of the healthcare system and the healthcare system's health care providers who are licensed under this title; and
  • (b)may not provide treatments that are authorized exclusively under this section to an individual who is not at least 18 years old.

• (4)Before July 1, 2026, a healthcare system that creates a behavioral health treatment program under this section shall provide a written report to the Health and Human Services Interim Committee regarding:
  • (a)drugs used;
  • (b)health outcomes of patients;
  • (c)side effects of any drugs used; and
  • (d)any other information necessary for the Legislature to evaluate the medicinal value of any drugs.

• (5)An individual or entity that complies with this section when using, distributing, possessing, administering, or supervising the use of, a drug is not guilty of a violation of this title.